Clinical trials - Press Releases

Date	Title	Company
07-Feb-2020	AI in healthcare sector in rude health	finnCap Group
07-Feb-2020	OGT launches breakthrough CytoSure NGS panel for constitutional cytogenetics	Oxford Gene Technology
07-Feb-2020	Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Study	Sumitomo Dainippon Pharma Co., Ltd
07-Feb-2020	Johnson & Johnson in Healthy Lead as World’s Most Valuable Pharma Brand	Brand Finance
07-Feb-2020	Panthera’s clinical trial site in Preston, UK, open for business	Panthera
07-Feb-2020	: Immutep activities report - late-stage Phase IIb metastatic breast cancer results ETA, TACTI-002 results ETA	Immutep
07-Feb-2020	2019 EBITDA ahead of market expectations Outlook underpinned by strong order book and Ashfield Pharmacovigilance acquisition	Ergomed plc
07-Feb-2020	Chiesi Group receives Top Employer Award in UK and Europe for eighth consecutive year	Chiesi
06-Feb-2020	Envision Pharma Group kick off 2020 by scooping a triple win at the PM Society Awards	Envision Pharma Group
03-Feb-2020	Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services	Inceptua
31-Jan-2020	Clinerion and Datametrix partner to deliver Real World Evidence (RWE) insights from Real World Data (RWD) from Clinerion’s global hospital network.	Clinerion Ltd
30-Jan-2020	Cynbiose receives €1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases	Cynbiose
30-Jan-2020	European Medicines Agency Validates Kite's Marketing Authorisation Application for Company's Second CAR T Cell Therapy	Kite
30-Jan-2020	Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell’s Gene Editing Platform and Oncology Product Portfolio	ABCAM PLC
30-Jan-2020	REGULATORY ANNOUNCEMENT: Astellas Submits sNDA for Approval of Evrenzo® (roxadustat)	Astellas Pharma Inc.
30-Jan-2020	Sanofi: Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency	Sanofi
30-Jan-2020	FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis	Sanofi
30-Jan-2020	Autolus Announces Closing of Public Offering	Autolus Therapeutics plc
30-Jan-2020	Agilent Introduces New Cutting-Edge SureSelect DNA Kit	Agilent Technologies Inc.
30-Jan-2020	NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer	NuCana plc